- Home
- CTRM vs ANVS Comparison
CTRM vs ANVS Comparison
Compare CTRM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- ANVS
- Stock Information
- Founded
- CTRM 2016
- ANVS 2008
- Country
- CTRM Cyprus
- ANVS United States
- Employees
- CTRM N/A
- ANVS N/A
- Industry
- CTRM Marine Transportation
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- CTRM Consumer Discretionary
- ANVS Health Care
- Exchange
- CTRM Nasdaq
- ANVS Nasdaq
- Market Cap
- CTRM 20.7M
- ANVS 24.2M
- IPO Year
- CTRM N/A
- ANVS 2020
- Fundamental
- Price
- CTRM $2.34
- ANVS $1.69
- Analyst Decision
- CTRM
- ANVS Strong Buy
- Analyst Count
- CTRM 0
- ANVS 4
- Target Price
- CTRM N/A
- ANVS $40.67
- AVG Volume (30 Days)
- CTRM 42.5K
- ANVS 507.4K
- Earning Date
- CTRM 05-23-2025
- ANVS 05-13-2025
- Dividend Yield
- CTRM N/A
- ANVS N/A
- EPS Growth
- CTRM N/A
- ANVS N/A
- EPS
- CTRM 2.39
- ANVS N/A
- Revenue
- CTRM $76,443,340.00
- ANVS N/A
- Revenue This Year
- CTRM N/A
- ANVS N/A
- Revenue Next Year
- CTRM N/A
- ANVS N/A
- P/E Ratio
- CTRM $1.02
- ANVS N/A
- Revenue Growth
- CTRM N/A
- ANVS N/A
- 52 Week Low
- CTRM $1.98
- ANVS $1.11
- 52 Week High
- CTRM $5.49
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- CTRM 55.58
- ANVS 56.79
- Support Level
- CTRM $2.07
- ANVS $1.48
- Resistance Level
- CTRM $2.58
- ANVS $1.74
- Average True Range (ATR)
- CTRM 0.13
- ANVS 0.18
- MACD
- CTRM 0.04
- ANVS 0.04
- Stochastic Oscillator
- CTRM 52.78
- ANVS 45.83
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.